Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds JMP Securities Downgrades iBio to Market Perform

JMP Securities Downgrades iBio to Market Perform

JMP Securities analyst Roy Buchanan downgrades iBio (AMEX:IBIO) from Market Outperform to Market Perform.

byBenzinga Newsdesk

February 16, 2023

1 minute read

JMP Securities analyst Roy Buchanan downgrades iBio (AMEX:IBIO) from Market Outperform to Market Perform.

Primerica’s Robust Potential In Middle-Market Consumers: Insights From Truist Securities Analyst

By Nabaparna Bhattacharya

July 10, 2:15 PM

Truist Securities analyst Mark Hughes reiterated a Buy rating on Primerica, Inc. (NYSE: PRI),

PRI

JPMorgan To Rally Over 29%? Here Are 10 Other Analyst Forecasts For Monday

By Lisa Levin

October 16, 9:27 AM

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page

AAPL

Quantum Corp Files For Stock Shelf Of Up To 361,010 Shares Of Common Stock By The Selling Stockholders

By Benzinga Newsdesk

December 29, 5:21 PM

-SEC Filing

QMCO

Tyson Foods CEO Says Retail Chicken Sales Were Lower Than Expected In November And December, Forcing Company To Resell Chicken At Lower Prices

By Happy Mohamed

February 6, 10:38 AM

- Reuters

TSN

JMP Securities Downgrades iBio to Market Perform

Related Posts

Primerica’s Robust Potential In Middle-Market Consumers: Insights From Truist Securities Analyst

JPMorgan To Rally Over 29%? Here Are 10 Other Analyst Forecasts For Monday

Quantum Corp Files For Stock Shelf Of Up To 361,010 Shares Of Common Stock By The Selling Stockholders

Tyson Foods CEO Says Retail Chicken Sales Were Lower Than Expected In November And December, Forcing Company To Resell Chicken At Lower Prices